BioSpace News Archive

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the two-year launch anniversary of RADICAVA ORS ® (edaravone) in the U.S.

MyMD Pharmaceuticals, Inc. today announced the appointment of Mitchell Glass, M.D., a member of the board of directors of the Company, as president and chief medical officer.

Northwest Biotherapeutics announced today that on June 12, 2024 it entered into an exclusive license from Roswell Park Comprehensive Cancer Center for a portfolio of dendritic cell technologies and intellectual property (IP).

MicroPort® CardioFlow Medtech Corporation (CardioFlow) (Stock Code: 02160.HK) recently announced that its self-developed second-generation transcatheter aortic valve implantation (TAVI) device, the VitaFlow LibertyTM Transcatheter Aortic Valve and Retrievable Delivery System (VitaFlow LibertyTM), has received EU CE-MDR certification.

SpineThera, Inc., a pharmaceutical company specializing in long-acting injectable technology, has announced it has entered into a know-how agreement with Mayo Clinic.

Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (“Defence” or the “Company”), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies

Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, announces publication of data from its Phase 1 dose escalation study of its lead personalized cancer vaccine candidate, EVX-01, for metastatic melanoma.

Raya Therapeutic Inc., is pleased to announce supportive clinical data for its lead compound, fasudil (RT1968, in the treatment of Amyotrophic Lateral Sclerosis (ALS)).

Longeveron Inc. today announced that it will participate in the Virtual Life Sciences Investor Forum taking place June 20, 2024.

Immix Biopharma, Inc. today announced that it will present and host institutional investor meetings at the Stifel 2024 Cell Therapy Forum.